Prashasti Dahiya: Key Molecular Insights on Thromboinflammation and Angiogenesis in Pediatric Cancer
Prashasti Dahiya, Clinical Physician Assistant at Ontario Cardiology Center, shared on LinkedIn about a recent article she and her colleagues co-authored, published in Annals of Medicine and Surgery, adding:
”Our review article has been published in Annals of Medicine and Surgery.
Title: Molecular regulators of thromboinflammation and angiogenesis in pediatric cancer: emerging roles of noncoding RNAs, epigenetics, and extracellular vesicles – narrative review
This review explores key molecular pathways driving thromboinflammation and angiogenesis in pediatric cancers, highlighting emerging roles of noncoding RNAs, epigenetic regulation, and extracellular vesicles.
I contributed to drafting multiple sections of the manuscript, led the creation of Figures 1 and 2, and was actively involved in finalizing the manuscript.
A key focus of my work was synthesizing how thrombosis, angiogenesis, and inflammation are intricately interconnected, with each process reinforcing the others.
I really enjoyed this process and gained a deeper understanding of these overlapping pathways.
Grateful to collaborate with such a dedicated team and for the guidance throughout this work.”
Title: Molecular regulators of thromboinflammation and angiogenesis in pediatric cancer: emerging roles of noncoding RNAs, epigenetics, and extracellular vesicles – narrative review
Authors: Shreya Singha Beniwal, Prashasti Dahiya, Manju Ramakrishnan, Rafael Everton Assunção Ribeiro da Costa, Akash Rawat, Yujin Jeong, Rajya Lakshmi Devarapalli, Alexandros Keramidas, Chimuka Mwaanga, Aarushi Mishra
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 30, 2026, 17:43Santagata Davide: Can Targeting Inflammation Help Prevent Thrombosis?
-
Oct 30, 2026, 17:38Patrick Ellsworth: Supporting Patients and Families Through Bleeding Disorders Awareness and Community Initiatives
-
Oct 30, 2026, 17:33Ed Shovelin: Comparative Hemostatic Performance of CRP-A and Equine Fibrillar Collagen
-
Oct 30, 2026, 16:52Tosin Ola: A New Era in Sickle Cell Disease Treatment and the Question of Access
-
Oct 30, 2026, 16:48Cedric Hermans: The Next Generation of FVIIIa-Mimetic Antibodies in Haemophilia A
-
Oct 30, 2026, 16:44Shehab Mohamed: Recognizing Isolated Thrombocytopenia as a Presentation of MDS
-
Oct 30, 2026, 16:40Amrita Sarkar: Advancing the Diagnosis of Anti-PF4 Syndromes
-
Oct 30, 2026, 16:35James Garrard: Driving Innovation in Stroke Care Through Global Collaboration
-
Oct 30, 2026, 16:19Cesar de Almeida Neto: Hemo 2026 Roundtable Focuses on the Challenges of Patient Blood Management